Asieris (亚虹医药)

formerly Asieris Pharmaceuticals

Asieris (亚虹医药) is a biotech company in Nanjing, China, founded in 2010. It has 2 recorded funding rounds, most recently an Extension Round in June 2020.

Improve Human Health to Preserve Patients' Dignity

Headquarters
Nanjing
Employees
51–200
Founded
2010
Business Model
B2B
Last Round
Extension RoundJun 2020
Rounds
2

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Asieris Pharmaceuticals is an innovative drug company focused on genitourinary tumors and women's health, with a stated mission to improve human health and preserve patients' dignity. Its marketed and pipeline products include Vesique (APL-1202) and Cevira (APL-1702), spanning urologic oncology, women's health, and breast and gynecologic oncology through in-house R&D and licensing. Technology platforms include Targeted Immunomodulator Normalization (TIMN), Prodrugs Accurate Drug Delivery (TAIDD), and fragment-based DDC chimeras. Recent milestones include FDA IND approval for a CLDN6/9 ADC for advanced solid tumors and China marketing approval for a blue-light cystoscopy system for bladder cancer.

Summary

It lists 51–200 employees. Its most recent funding was an Extension Round in Jun 2020. Investors include Tigermed Investment and BioTrack Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries C+Jun 2020

Sign up to see all 2 events

Funding: Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Asieris (亚虹医药) on Indexed.vc
<a href="https://indexed.vc/companies/asieris"><img src="https://indexed.vc/api/badge/company/asieris" alt="Asieris (亚虹医药) on Indexed.vc" width="260" height="76" /></a>